Kyma Technologies Signs 3 Year Research Agreement with US Navy

Kyma Technologies, Inc., a leading supplier of ultra-high purity crystalline gallium nitride (GaN) and aluminum nitride (AlN) materials and related products and services, announced the signing of a US Navy Cooperative Research and Development Agreement (CRADA) between the company and Naval Surface Warfare Center – Crane Division (NSWC Crane).

The CRADA formalizes and expands upon an ongoing effort between Kyma and NSWC Crane, who have been informally collaborating for over a year on advanced materials characterization analyses of Kyma’s native GaN products. The CRADA Principal Investigators are Chuck Pagel of NSWC Crane and Drew Hanser of Kyma.

Dr. Hanser, who is Kyma’s Chief Technology Officer and Vice President of Business Development, stated, “NSWC Crane’s capabilities include a number of advanced materials and device characterization and analysis tools and associated expertise. Formalization of this important collaboration represents an important step for Kyma towards furthering our understanding of how to bring better materials solutions to our customers.”

Kyma’s CEO Dr. Keith Evans added, “It has been a great pleasure getting to know Chuck and his colleagues and to work with their team. We have already benefited in several ways from this collaboration. A very recent example is the characterization of impurity concentrations within our GaN crystalline boules. This represents important feedback for Kyma’s native GaN crystal growth effort.”

Kyma’s Chief Scientist, Dr. Tanya Paskova, will present some of the recent characterization results from collaboration with the NSWC Crane group in her presentation next month in the Opto 2008 Symposium of Photonics West 2008, which will be held during the week of January 19th – 24th in San Jose, CA.

The CRADA covers a period of three (3) years.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.